Clinical Research Development Ireland
Clinical Research Development Ireland (https://www.crdi.ie/) is a not-for-profit research partnership comprising NUI Galway, Royal College of Surgeons in Ireland, Trinity College Dublin, University College Cork and University College Dublin, their medical schools, associated academic hospitals and clinical research facilities, with the objective of accelerating the translation of biomedical research into improved diagnostics, therapies and devices for patients.
Ireland East Hospital Group
The Ireland East Hospital Group (IEHG) is the largest and most complex of Ireland’s hospital groups. Comprising 11 hospitals (6 voluntary and 5 statutory), IEHG spans eight counties and works with four Community Health Organisation (CHO) partners. In collaboration with UCD, the academic partner, IEHG’s ambition is to be the national leader in healthcare delivery, working to improve the quality of healthcare and deliver better patient outcomes through education, training, research and innovation for the over 1 million people.
Cancer Clinical Academic Directorate
The Cancer Clinical Academic Directorate is the first Clinical Academic Directorate developed in the Ireland East Hospital Group and was launched in June 2016 by IEHG CEO Mary Day and the Director of the National Cancer Control Programme Dr Jerome Coffey. The aim is to align the two cancer centres at the Mater Misericordiae University Hospital and St. Vincent’s University Hospital into a single function operating across two sites which will combine the strength and scale of clinical cancer services at both hospitals together with the cutting edge research of UCD to enhance the care given to cancer patients across our Group.
National Institute for Bioprocessing Research & Training
The National Institute for Bioprocessing Research and Training (NIBRT) is a world-class institute that provides training and research solutions for the bioprocessing industry in state of the art facilities. NIBRT is located in Dublin, Ireland and is based on an innovative collaboration between University College Dublin, Trinity College Dublin, Dublin City University and Institute of Technology Sligo.
NIBRT supports the bioprocessing industry by providing a unique learning experience for trainees in an environment that replicates the most modern industrial bioprocessing facility. In parallel, they also undertake leading edge research in key areas of bioprocessing in collaboration with industry.
Centre for Synthesis & Chemical Biology
The Centre for Synthesis & Chemical Biology (CSCB) is a collaboration in the chemical sciences between University College Dublin (UCD), Trinity College Dublin (TCD) and the Royal College of Surgeons in Ireland (RCSI). The UCD centre forms part of the UCD Conway Institute of Biomolecular and Biomedical Research. The centre was established in December 2001 and officially opened by An Taoiseach, Mr Bertie Ahern TD on February 2, 2006.
Chemical biology incorporates research that provides an understanding of the chemical basis of biology; development and use of biological tools for chemistry; development and use of chemical tools for biology and medicine. Within interdisciplinary research projects, the design, synthesis and analysis of components is carried out by investigators within the CSCB while biological testing is done in collaboration with colleagues within UCD Conway Institute. Expertise within the centre encompasses these areas with a specific emphasis in bioactive molecule design and synthesis; synthetic and biosynthetic methodology development, analytical, computational, structural and supramolecular chemistry. Specific areas of interest within the centre include: carbohydrates, combinatorial chemistry, natural products, enzyme mechanisms, enzymes in synthesis, asymmetric catalysis, medicinal chemistry, bioinorganic chemistry, drug delivery, sensors and imaging.